Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

On Target Therapeutics LLC
Profile last edited on: 7/13/17      CAGE: 79X94      UEI: GCV9NBJ4BRS1

Business Identifier: Therapeutics for neuropathic pain
Year Founded
2015
First Award
2016
Latest Award
2016
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1 Harrington Lane
Weston, MA 02493
   (617) 564-3586
   vittorio.montanari@icloud.com
   N/A
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

On Target Therapeutics is developing a novel treatment of neuropathic pain. Neuropathic pain affects millions of people worldwide and remains a serious unmet medical need. A significant fraction of patients receive little or no relie from existing therapies. The successful development of the firm's candidate compound provide a novel treatment option for individuals suffering from neuropathic pain. The technology is based on developing stable long acting peptide modulators of G protein coupled receptors.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$223,900
Phase II Dollars
$0
Total Awarded
$223,900

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2016 1 NIH $223,900
Project Title: Lipidated Stable BAM8-22 Offers a Promising Therapeutic for Neuropathic Pain

Key People / Management

  Alan S Kopin

Company News

There are no news available.